Catheter ablation for non-valvular atrial fibrillation
Part of Heart & circulation clinical trials.
This trial studies catheter ablation, a procedure that targets heart rhythm triggers, for people with atrial fibrillation (an irregular heartbeat). It may help improve rhythm control, but you must meet specific heart and testing requirements and avoid certain conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have non-valvular atrial fibrillation (not related to a heart valve problem), like paroxysmal or persistent types
- You are between 18 and 80 years old
- Your left atrium size is below 50 mm on an ultrasound test of the heart (TTE)
- Specialists say you are a candidate for bilateral pulmonary vein isolation (a targeted ablation plan) after heart testing
- You agree to have the ablation procedure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a newer ablation technique called pulsed field ablation to treat atrial fibrillation, a heart rhythm disorder. The goal is to see if this method works well and is safe for patients who need treatment.
This trial compares two procedures to treat atrial fibrillation (an irregular heartbeat) in people who also have hypertrophic cardiomyopathy (thickened heart muscle). It looks at whether the hybrid approach or a catheter-based approach works better for controlling symptoms and heart rhythm.
This trial is studying a way to improve the entire process of catheter ablation for atrial fibrillation. It may help people who are having this procedure for the first time and have a normal-sized left atrium and good heart function.
This trial is testing a new way to treat atrial fibrillation by using a catheter to target the specific areas in the heart that trigger the irregular heartbeat. If you have persistent atrial fibrillation and haven't had prior catheter ablation, you may be eligible to join.
This study tests a new approach to catheter ablation for people with persistent atrial fibrillation (a type of irregular heartbeat). It may be an option if you have not responded well to or could not tolerate a rhythm-control medication.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.